EPISODE · May 5, 2026 · 1 MIN
Pfizer's Q1 2026 Earnings: Beating Estimates with New Drugs
from The Daily News Now! Business
Pfizers Q1 2026 earnings soar, beating estimates with $14.45 billion revenue, up 5% YoY. Earnings per share strong despite COVID impact. Newer drugs and acquisitions drive 22% operational growth. Oncology and primary care lead with 7% and 8% growth respectively. Pfizer maintains full-year targets, pivoting from pandemic peaks with promising new medications. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/d4f2cdde2d03c6d3
NOW PLAYING
Pfizer's Q1 2026 Earnings: Beating Estimates with New Drugs
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m